Acutely administered melatonin decreases somatostatin-binding sites and the inhibitory effect of somatostatin on adenylyl cyclase activity in the rat hippocampus

Journal of Pineal Research

Volumn 36, Issue 2, 2004, Pages 87-94

  Izquierdo Claros, Rosa María ^a   Boyano Adánez, María Del Carmen ^a   Arilla Ferreiro, Eduardo ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Adenylyl cyclase; G proteins; Hippocampus; Melatonin; Rat; Somatostatin receptors

Indexed keywords

ADENYLATE CYCLASE; ALCOHOL; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; LUZINDOLE; MELATONIN; SODIUM CHLORIDE; SOMATOSTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG INHIBITION; DRUG MECHANISM; HIPPOCAMPUS; IMMUNOREACTIVITY; MALE; NERVE CELL; NONHUMAN; RAT; RECEPTOR BINDING; RECEPTOR BLOCKING; WESTERN BLOTTING;

ADENYLATE CYCLASE; ANIMALS; BLOTTING, WESTERN; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; MELATONIN; RATS; SOMATOSTATIN;

EID: 1342343945     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1600-079X.2003.00100.x     Document Type: Article

References (59)

1. REPPERT SM, PERLOW MJ, TAMARKIN L et al. A diurnal melatonin rhythm in primate cerebrospinal fluid. Endocrinology 1979; 104:295-301.
2. SKINNER DC, MALPAUX B. High melatonin concentration in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus. Endocrinology 1999; 140:4399-4405.
3. LAUDON M, NIR I, ZISAPEL N. Melatonin receptors in discrete brain areas of the male rat. Impact for aging on density and on circadian rhythmicity. Neuroendocrinology 1988; 48:577-583.
4. STANKOV B, FRASCHINI F, REITER RJ. Melatonin binding sites in the central nervous system. Brain Res Rev 1991; 16:245-256.
5. 3H]muscimol binding in rat brain. Biochem Pharmacol 1988; 37:1271-1274.
6. LI GL, LI P, YANG XL. Melatonin modulates gamma-aminobutyric acid (A) receptor-mediated currents on isolated carp retinal neurons. Neurosci Lett 2001; 301:49-53.
7. ACUÑA-CASTROVIEJO D, ROSENSTEIN RE, ROMEO HE et al. Changes in gamma-aminobutyric acid high affinity binding to cerebral cortex membranes after pinealectomy or melatonin administration to rats. Neuroendocrinology 1986; 43:24-31.
8. REITER RJ, TAN DX, MANCHESTER LC et al. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys 2001; 34:237-256.
9. ALLEGRA M, REITER RJ, TAN DX et al. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003; 34:1-10.
10. ACUÑA-CASTROVIEJO D, ESCAMES G, MACIAS M et al. Cell protective role of melatonin in the brain. J Pineal Res 1995; 19:57-63.
11. MUSSHOFF U, RIEWENHERM D, BERGER D et al. Melatonin receptors in rat hippocampus: molecular and function investigations. Hippocampus 2002; 12:165-173.
12. WAN Q, MAN HY, LIN F et al. Differential modulation of GABAA receptor function by Mella and Mellb receptors. Nat Neurosci 1999; 2:401-403.
13. BOEHM S, BETZ H. Somatostatin inhibits excitatory transmission at rat hippocampal synapses via presynaptic receptors. J Neurosci 1997; 17:4066-4075.
14. TALLENT MK, SIGGINS GR. Somatostatin depresses excitatory but not inhibitory neurotransmission in rat CA1 hippocampus. J Neurophysiol 1997; 78:3008-3018.
15. BAKST I, AVENDANO C, MORRISON JH et al. An experimental analysis of origins of somatostatin-like immunoreactivity in the dentate gyrus of the rat. J Neurosci 1986; 6:1452-1462.
16. REUBI JC, MAURER R. Autoradiographic mapping of somatostatin receptors in the rat central nervous system and pituitary. Neuroscience 1985; 15:1183-1193.
17. PETRUSZ P, SAR M, GROSSMAN GH et al. Synaptic terminals with somatostatin-like immunoreactivity in the rat brain. Brain Res 1977; 137:181-187.
18. SCHONBRUNN A. Somatostatin receptors: present knowledge and future directions. Ann Oncol 1999; 10:S17-S21.
19. LAW SF, MANNING D, REISINE T. Identification of the subunits of GTP-binding proteins coupled to somatostatin receptors. J Biol Chem 1991; 266:17885-17897.
20. DORFLINGER LJ, SCHONBRUNN A. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells. Endocrinology 1983; 113:1551-1558.
21. MEYERHOF W. The elucidation of somatostatin receptor functions: a current view. Rev Physiol Biochem Pharmacol 1998; 133:55-108.
22. ALEXIUK NA, VRIEND JP. Melatonin reduces dopamine content in the neurointermediate lobe of male syrian hamsters. Brain Res Bull 1993; 32:433-436.
23. DUBOCOVICH ML, MOGILNICKA E, ARESO PM. Antidepressant-like activity of the melatonin receptor antagonist, luzindole (N-0774), in the mouse behavioral despair test. Eur J Pharmacol 1990; 182:313-325.
24. 3H]DOPA in various regions of the brain. J Neurochem 1966; 13:655-669.
25. 131I-labelled human growth hormone of high specific radioactivity. Biochem J 1963; 89:114-123.
26. REUBI JC, PERRIN MH, RIVIER JE et al. High affinity binding sites for a somatostatin-28 analog in rat brain. Life Sci 1981; 28:2191-2198.
27. LOWRY OH, ROSENBROUGH NJ, FARR AL et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-275.
28. CZERNIK AJ, PETRACK V. Somatostatin receptor binding in rat cerebral cortex. Characterization using a nonreducible somatostatin analog. J Biol Chem 1983; 285:5525-5530.
29. PATEL YC, REICHLIN S. Somatostatin in hypothalamus, extrahypotalamic brain, and peripheral tissues of the rat. Endocrinology 1978; 102:523-530.
30. HOUSLAY MD, METCALFE JC, WARREN GB et al. The glucagon receptor of rat liver plasma membrane can couple to adenylate cyclase without activating it. Biochim Biophys Acta 1976; 436:489-494.
31. GILMAN AG. A protein binding assay for adenosine 3′5′-cyclic monophosphate. Proc Natl Acad Sci USA 1970; 67:305-312.
32. SCHETTINI G, FLORIO T, MEUCCI O et al. Somatostatin inhibition of adenylate cyclase activity in different brain areas. Brain Res 1989; 492:65-71.
33. LAEMMLI UK. Cleaveage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
34. MUNSON PJ, RODBARD D. A versatile computerized approach for characterization of ligand binding systems. Anal Biochem 1980; 107:220-239.
35. ACUÑA-CASTROVIEJO D, CASTILLO JL, FERNÁNDEZ B et al. Modulation by pineal gland of ouabain high-affinity binding sites in rat cerebral cortex. Am J Physiol 1992; 262: R698-R706.
36. PITKANEN A, SIRVIO J, JOLKONNNE J et al. Somatostatin-like immunoreactivity and somatostatin receptor binding in rat brain before and after pentylenetetrazol induced convulsion. Neuropeptides 1986; 7:63-71.
37. 1-somatostatin binding sites in rat brain. J Neurochem 1982; 38:1515-1523.
38. NILES LP, PEACE CH. Allosteric modulation of t-[35S] butylbicyclophosphorothionate binding in rat brain by melatonin. Brain Res Bull 1990; 24:635-638.
39. MARTINEZ A, ARILLA E. The effect of diazepam and the benzodiazepine antagonist CGS8216 on the somatostatinergic neuronal system. Neuropharmacology 1993; 32:393-399.
40. GULYÁS AI, GÖRCS TJ, FREUND TF. Innervation of different peptide-containing neurons in the hippocampus by gabaergic septal afferents. Neuroscience 1990; 37:31-44.
41. A receptors containing the alpha1 subunit to neurochemically distinct subpopulations of rat hippocampal interneurons. Eur J Neurosci 1994; 6:837-853.
42. EPELBAUM J, DOURNAUD P, FODOR M et al. The neurobiology of somatostatin. Crit Rev Neurobiol 1994; 8:25-44.
43. KOSAKA T, WU JY, BENOIT R. GABAergic neurons containing somatostatin-like immunoreactivity in the rat hippocampus and dentate gyrus. Exp Brain Res 1988; 71:388-398.
44. GAMSE R, VACCARO D, GAMSE G et al. Release of immunoreactive somatostatin from hypothalamic cells in culture: inhibition by gamma-aminobutyric acid. Proc Natl Acad Sci USA 1980; 77:5552-5556.
45. A receptor stimulation in mouse brain. Mol Brain Res 1992; 13:277-281.
46. RAMIREZ JL, MOUCHANTAF R, KUMAR U et al. Brain somatostatin receptors are up-regulated in somatostatin-deficient mice. Mol Endocrinol 2002; 16:1951-1963.
47. GONZÁLEZ-GUIJARRO L, LÓPEZ-RUIZ MP, PRIETO JC et al. Modulation of somatostatin binding sites in cytosol of rabbit gastric fundic mucosa by cisteamine administration. Gen Pharmacol 1986; 17:637-639.
48. SRIKANT CB, PATEL YC. Cysteamine-induced depletion of brain somatostatin is associated with up-regulation of cerebrocortical somatostatin receptors. Endocrinology 1984; 115:990-995.
49. LILES WC, NATHANSON NM. Regulation of muscarinic acetylcholine receptor number in cultured neuronal cells by chronic membrane depolarization. J Neurosci 1987; 7:2556-2563.
50. PUEBLA L, ARILLA E. Glycine increases the number of somatostatin receptors and somatostatin-mediated inhibition of adenylate cyclase system in the rat hippocampus. J Neurosci Res 1996; 43:346-354.
51. GARLIND A, FOWLER CJ, ALAFUZOFF I et al. Neurotransmitter-mediated inhibition of post-morten human brain adenylyl cyclase. J Neural Transm Gen Sect 1992; 87:113-124.
52. NAGAO M, SAKAMOTO C, MATOZAKI T et al. Coupling of inhibitory GTP binding protein to somatostatin receptors on rat cerebrocortical membranes. Nippon Naibunpi Gakkai Zasshi 1989; 65:1357-1366.
53. 1-somatostatin binding in rat adenohypophysis and cerebral cortex. Endocrinology 1983; 113:822-824.
54. IZQUIERDO-CLAROS RM, BOYANO-ADÁNEZ MC, TORRECILLAS G et al. Acute modulation of somatostatin receptor function by melatonin in the rat frontoparietal cortex. J Pineal Res 2001; 31:46-56.
55. IZQUIERDO-CLAROS RM, BOYANO-ADÁNEZ MC, ARILLA-FERREIRO E. Effects of subchronic and chronic melatonin treatment on somatostatin binding and its effects on adenylyl cyclase activity in the rat frontoparietal cortex. J Pineal Res 2002; 33:1-9.
56. 1b, recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor. Naunyn Schmiedebergs Arch Pharmacol 1997; 355:365-375.
57. DUBOCOVICH ML. Pharmacology and function of melatonin receptors. FASEB J 1988; 2:2765-2773.
58. DRAZNIN B, SHERMAN N, SUSSMAN K et al. Internalization and cellular processing of somatostatin in primary culture of rat anterior pituitary cells. Endocrinology 1985; 117:960-966.
59. CSABA Z, BERNARD V, HELBOE L et al. In vivo internalization of the somatostatin sst2A receptor in rat brain: evidence for translocation of cell-surface receptors into the endosomal recycling pathway. Mol Cell Neurosci 2001; 17:646-661.